全文获取类型
收费全文 | 110084篇 |
免费 | 10543篇 |
国内免费 | 2451篇 |
专业分类
耳鼻咽喉 | 3109篇 |
儿科学 | 1273篇 |
妇产科学 | 1834篇 |
基础医学 | 5574篇 |
口腔科学 | 3173篇 |
临床医学 | 10047篇 |
内科学 | 8226篇 |
皮肤病学 | 811篇 |
神经病学 | 2605篇 |
特种医学 | 2671篇 |
外国民族医学 | 92篇 |
外科学 | 30670篇 |
综合类 | 14670篇 |
现状与发展 | 12篇 |
一般理论 | 3篇 |
预防医学 | 4267篇 |
眼科学 | 4686篇 |
药学 | 4969篇 |
187篇 | |
中国医学 | 1464篇 |
肿瘤学 | 22735篇 |
出版年
2024年 | 386篇 |
2023年 | 2618篇 |
2022年 | 4388篇 |
2021年 | 5904篇 |
2020年 | 5728篇 |
2019年 | 4950篇 |
2018年 | 4712篇 |
2017年 | 4321篇 |
2016年 | 4418篇 |
2015年 | 4853篇 |
2014年 | 8034篇 |
2013年 | 7883篇 |
2012年 | 6257篇 |
2011年 | 6585篇 |
2010年 | 5171篇 |
2009年 | 4907篇 |
2008年 | 4777篇 |
2007年 | 4882篇 |
2006年 | 4482篇 |
2005年 | 3976篇 |
2004年 | 3399篇 |
2003年 | 2925篇 |
2002年 | 2370篇 |
2001年 | 2185篇 |
2000年 | 1831篇 |
1999年 | 1639篇 |
1998年 | 1334篇 |
1997年 | 1265篇 |
1996年 | 988篇 |
1995年 | 813篇 |
1994年 | 673篇 |
1993年 | 565篇 |
1992年 | 475篇 |
1991年 | 468篇 |
1990年 | 322篇 |
1989年 | 306篇 |
1988年 | 305篇 |
1987年 | 291篇 |
1986年 | 246篇 |
1985年 | 284篇 |
1984年 | 246篇 |
1983年 | 163篇 |
1982年 | 182篇 |
1981年 | 175篇 |
1980年 | 115篇 |
1979年 | 83篇 |
1978年 | 61篇 |
1977年 | 50篇 |
1976年 | 41篇 |
1975年 | 25篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
《Cancer radiothérapie》2022,26(4):611-615
In order to provide more convenient irradiation regimens for patient comfort, radiation facility organization and health expenses, new hypofractionated protocols have been evaluated. Moderately (dose/fraction: 2.3 to 3 Gy), then ultra (dose/fraction: 5.2 to 6.1 Gy) hypofractionated irradiations were first validated. The current question is: is it possible to go forward using extreme hypofractionated regimens (EHR) based on 1 to 3 fractions. Different irradiation techniques are under investigation. However, brachytherapy remains the smartest way to deliver a high dose in a small volume. We report prospective and retrospective study results which evaluated EHR for breast and prostate brachytherapy. While oncological outcome and toxicity profile appear extremely encouraging for low-risk breast cancer after a 1 to 4 fractions (6.25 to 20 Gy/fraction), the use of a single fraction of 19 to 23 Gy appears debatable for prostate cancer. Brachytherapy represents an emblematic example of EHR but longer follow-up and more mature results are awaited in order to specify the right indications and refine the EQD2 calculation method including new biological and technical factors. 相似文献
2.
3.
4.
5.
6.
7.
《Cirugía espa?ola》2022,100(3):149-153
IntroductionThe Law for the Regulation of Health Professions (LOPS) indicates that health professionals will carry out continuous training throughout their professional life, and will regularly prove their professional competence. The objective of the study was to carry out a national survey to find out the opinion of Spanish surgeons and thus be able to prepare a recertification project by the Spanish Association of Surgeons (AEC).MethodsCross-sectional observational study carried out in June-July 2020, through a survey sent to the members of the AEC.ResultsThe survey had a total of 1230 visits and an overall completion rate of 784 responses (67.3%). 69.6% were unaware of the LOPS forecasts and 83.4% were unaware of similar initiatives in other specialties and 95.5% agreed to demand adequate information. 71.4% believed it necessary but only 57% believed that it should be mandatory. 82.9% would agree that it should be regulated through an objective and predictable official procedure.ConclusionsThe concept of re-accreditation is not well known in our specialty and in view of the results obtained, adequate and reliable information seems necessary. Therefore, it would be pertinent to propose by the AEC a specific project to assess activities and skills. 相似文献
8.
《Diagnostic Histopathology》2022,28(3):156-160
Breast core biopsies are a standard component of the triple approach that includes clinical examination, imaging and tissue sampling. Conventional cores, diagnostic vacuum assisted biopsy and vacuum assisted excisions are established methods for sampling and managing breast lesions. It is important to be aware of the potential pitfalls in the technical handling and interpretation of the limited core biopsy samples. Here, we present a clinically oriented, well illustrated overview of the common diagnostic pitfalls based on the author's diagnostic and second opinion practice, emphasize the value of clinicopathological correlation and provide histological tips and clues with useful immunohistochemistry to aid the reporting pathologists in their daily interpretation of breast core biopsies. 相似文献
9.
Mette Nissen Tiina‐Mari Ikheimo Jukka Huttunen Ville Leinonen Henna‐Kaisa Jyrkknen Mikael von und zu Fraunberg 《Neuromodulation》2021,24(1):102-111
ObjectiveSpinal cord stimulation (SCS) is an effective treatment in failed back surgery syndrome (FBSS). We studied the effect of preimplantation opioid use on SCS outcome and the effect of SCS on opioid use during a two-year follow-up period.Materials and methodsThe study cohort included 211 consecutive FBSS patients who underwent an SCS trial from January 1997 to March 2014. Participants were divided into groups, which were as follows: 1) SCS trial only (n = 47), 2) successful SCS (implanted and in use throughout the two-year follow-up period, n = 131), and 3) unsuccessful SCS (implanted but later explanted or revised due to inadequate pain relief, n = 29). Patients who underwent explantation for other reasons (n = 4) were excluded. Opioid purchase data from January 1995 to March 2016 were retrieved from national registries.ResultsHigher preimplantation opioid doses associated with unsuccessful SCS (ROC: AUC = 0.66, p = 0.009), with 35 morphine milligram equivalents (MME)/day as the optimal cutoff value. All opioids were discontinued in 23% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.004). Strong opioids were discontinued in 39% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.04). Mean opioid dose escalated from 18 ± 4 MME/day to 36 ± 6 MME/day with successful SCS and from 22 ± 8 MME/day to 82 ± 21 MME/day with unsuccessful SCS (p < 0.001).ConclusionsHigher preimplantation opioid doses were associated with SCS failure, suggesting the need for opioid tapering before implantation. With continuous SCS therapy and no explantation or revision due to inadequate pain relief, 39% of FBSS patients discontinued strong opioids, and 23% discontinued all opioids. This indicates that SCS should be considered before detrimental dose escalation. 相似文献